Bio-Techne Corp
TECH: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$42.00 | Dlpmy | Xdrwttckr |
Narrow-Moat Bio-Techne Building Protein Capacity and Growing Genomics, Increasing FVE to $200
Business Strategy and Outlook
Bio-Techne is a market leader in proteins for the pharma, biotech, academic, and diagnostic markets, and maintains strong market positioning in antibodies and testing controls for diagnostic partners.